The focus of the study in dialysis patients, in whom bacterial infections often compromise tunnelled cuffed catheters - a ...

Professor Mignon McCulloch, head of the Clinical Unit of Paediatric Nephrology and Solid Organ Transplantation at the Red Cross War Memorial Children’s Hospital (RCWMCH), highlights the need for a ...

In addition, recent episodes of transmission of bloodborne hepatitis viruses in outpatient healthcare facilities, including hemodialysis centers, related to suboptimal infection control and ...

CorMedix Inc.'s DefenCath, FDA-approved in Q4 2023, effectively prevents catheter-related bloodstream infections in hemodialysis patients, showing 71% efficacy compared to competitors. Despite ...

CorMedix Inc.'s DefenCath reduces catheter infections by 71% ... For context, CVCs are usually utilized in patients new to dialysis. It is not long-term access like AV fistulas.